Back to Search Start Over

Percutaneous device closure of Abernethy malformation--a treatable cause of hepatopulmonary syndrome.

Authors :
Venkateshwaran S
Krishnamoorthy KM
Sivasankaran S
Source :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2014 May 01; Vol. 83 (6), pp. 968-70. Date of Electronic Publication: 2013 Nov 19.
Publication Year :
2014

Abstract

An eight-year-old girl was evaluated for unexplained cyanosis. A contrast echo was suggestive of pulmonary arteriovenous fistula. Further evaluation revealed Abernethy malformation (type 2) leading to hepatopulmonary syndrome. Percutaneous device closure of Abernethy malformation was done after anatomical and physiological evaluation of the portal circulation. Prior to closure, it is important to ensure adequate portal radicals into the liver and normal portal pressure after test balloon occlusion. Subcostal echocardiography can diagnose and guide device closure of Abernethy malformation, a treatable cause of hepatopulmonary syndrome.<br /> (Copyright © 2013 Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
1522-726X
Volume :
83
Issue :
6
Database :
MEDLINE
Journal :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Publication Type :
Academic Journal
Accession number :
24248907
Full Text :
https://doi.org/10.1002/ccd.25275